Richard A. Brown - Tokyo
Richard Brown, a U.S. national, joined Plexus Ventures in 2006 following 26 years at Eli Lilly and Company, where he held positions in Business Development, Marketing and General Management.
Rich received an MBA from Harvard Business School in 1979, before entering an accelerated management program at Lilly, with initial assignments in U.S. sales and market research. After entering management in 1983, Rich held positions in sales management, market research and brand management, before being transferred to Kobe, Japan in 1991 to head up Lilly-Japan’s nascent market research and new product planning group. Returning in 1994 to direct Lilly’s US contract pricing group, Rich was again sent abroad to Moscow as managing director of Lilly-CIS. Since then, Rich has held management roles in marketing capabilities assessment, customer relationship management and, most recently, business development, with responsibility for Japan and West Coast US biotech collaborations. Announced in July 2005, Lilly’s in-license of Taisho Pharmaceutical’s DPPIV inhibitor in Phase 1 was negotiated by Rich.
Rich’s hands-on experience in the USA, Japanese and Russian pharmaceutical markets has allowed him to apply a variety of successful strategies and to obtain insight into the differential drivers of success in each market.
Tel: +81-3-6279-3570
